"What’s going on with immune cells in the blood seems to have a huge impact on cancer survival and may be able to predict how long a cancer patient will survive better than the number of T cells in the tumor alone," said Professor Nicholas McGranahan (UCL Cancer Institute).
Read: Technology Networks, UCL News
Close
